scispace - formally typeset
R

Ruma G. Singh

Researcher at University of Auckland

Publications -  39
Citations -  1164

Ruma G. Singh is an academic researcher from University of Auckland. The author has contributed to research in topics: Diabetes mellitus & Acute pancreatitis. The author has an hindex of 18, co-authored 38 publications receiving 856 citations. Previous affiliations of Ruma G. Singh include Purdue Pharma & Columbia University.

Papers
More filters
Journal ArticleDOI

Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression.

TL;DR: It is indicated that NAFPD is a frequent clinical entity, associated with significantly increased risk of metabolic syndrome and its components, and the normal pancreatic fat percentage threshold of 6.2% may be recommended for use in future prospective studies.
Journal ArticleDOI

Pancreas volume in health and disease: a systematic review and meta-analysis

TL;DR: The aim was to systematically review studies in adults that used computed tomography or magnetic resonance imaging to measure pancreas volume in health and disease, to determine normal pancreasant volume range, and to quantify changes in pancreAS volume that are associated with disease.
Journal ArticleDOI

Ectopic fat accumulation in the pancreas and its biomarkers: A systematic review and meta‐analysis

TL;DR: Circulating levels of triglycerides and glycated haemoglobin appear to be the best currently available markers of pancreaticFat in blood, and the approach of non‐invasive and accurate detection of pancreas fat by blood analysis should be further explored in the future.
Journal ArticleDOI

Comprehensive analysis of body composition and insulin traits associated with intra-pancreatic fat deposition in healthy individuals and people with new-onset prediabetes/diabetes after acute pancreatitis.

TL;DR: Body composition and insulin traits as biomarkers of IFD in healthy normoglycaemic individuals as well as in individuals with new‐onset prediabetes or diabetes after acute pancreatitis (NODAP) were analysed comprehensively.